GR79196B - - Google Patents
Info
- Publication number
- GR79196B GR79196B GR71595A GR830171595A GR79196B GR 79196 B GR79196 B GR 79196B GR 71595 A GR71595 A GR 71595A GR 830171595 A GR830171595 A GR 830171595A GR 79196 B GR79196 B GR 79196B
- Authority
- GR
- Greece
- Prior art keywords
- esters
- bromo
- chloro
- independently
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP82401119 | 1982-06-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
GR79196B true GR79196B (el) | 1984-10-22 |
Family
ID=8189916
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR71595A GR79196B (el) | 1982-06-18 | 1983-06-09 |
Country Status (25)
Country | Link |
---|---|
US (1) | US4587262A (el) |
EP (1) | EP0099177B1 (el) |
JP (1) | JPS5951240A (el) |
KR (1) | KR840005068A (el) |
AT (1) | ATE21686T1 (el) |
AU (1) | AU562207B2 (el) |
CA (1) | CA1221983A (el) |
CS (2) | CS241088B2 (el) |
DD (1) | DD210029A5 (el) |
DE (1) | DE3365634D1 (el) |
DK (1) | DK278283D0 (el) |
ES (3) | ES523376A0 (el) |
FI (1) | FI832227L (el) |
GB (1) | GB8313634D0 (el) |
GR (1) | GR79196B (el) |
HU (1) | HU191531B (el) |
IE (1) | IE55531B1 (el) |
IL (1) | IL68950A (el) |
NO (1) | NO832203L (el) |
NZ (1) | NZ204625A (el) |
PH (1) | PH20587A (el) |
PL (1) | PL242535A1 (el) |
PT (1) | PT76889B (el) |
ZA (1) | ZA834135B (el) |
ZW (1) | ZW12983A1 (el) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8313634D0 (en) * | 1982-06-18 | 1983-06-22 | Ici Plc | Halogenophenyl glyceride esters |
US4642366A (en) * | 1984-03-05 | 1987-02-10 | Stauffer Chemical Company | Process for preparing methyl phosphonamides |
BR9713348A (pt) * | 1996-11-12 | 2000-08-08 | Dov Tamarkin | Método para tratamento de distúrbios dermatológicos |
JP4226324B2 (ja) * | 2000-11-10 | 2009-02-18 | 学校法人早稲田大学 | カルボン酸型脂質 |
FR2839448A1 (fr) * | 2002-05-07 | 2003-11-14 | Oreal | Utilisation d'esters de triclosan, de piroctone et de tropolone dans une composition a liberation controlee |
US8026285B2 (en) | 2007-09-04 | 2011-09-27 | Bezwada Biomedical, Llc | Control release of biologically active compounds from multi-armed oligomers |
US8048980B2 (en) | 2007-09-17 | 2011-11-01 | Bezwada Biomedical, Llc | Hydrolysable linkers and cross-linkers for absorbable polymers |
US8053591B2 (en) | 2007-09-26 | 2011-11-08 | Bezwada Biomedical, Llc | Functionalized biodegradable triclosan monomers and oligomers for controlled release |
JP6336902B2 (ja) * | 2011-06-22 | 2018-06-06 | ビョーメ バイオサイエンシズ ピーブイティー.リミテッド | コンジュゲートベースの抗真菌性および抗菌性プロドラッグ |
CN117164657A (zh) | 2014-08-12 | 2023-12-05 | 莫纳什大学 | 定向淋巴的前药 |
WO2017041139A1 (en) | 2015-09-08 | 2017-03-16 | Monash University | Lymph directing prodrugs |
US11883497B2 (en) | 2017-08-29 | 2024-01-30 | Puretech Lyt, Inc. | Lymphatic system-directing lipid prodrugs |
EP4262778A1 (en) * | 2020-12-21 | 2023-10-25 | The Research Foundation for The State University of New York | Penetrating cryoprotection agents and methods of making and using same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL133434C (el) * | 1963-02-22 | 1972-02-15 | ||
CH431780A (de) * | 1963-02-22 | 1967-03-15 | Geigy Ag J R | Reinigungsmittel |
US3506720A (en) * | 1963-02-22 | 1970-04-14 | Geigy Chem Corp | Halogenated hydroxy-diphenyl ethers |
GB1051823A (el) * | 1964-02-14 | |||
FR1441499A (fr) * | 1964-02-14 | 1966-06-10 | Geigy Ag J R | Nouveaux esters phényliques doués de propriétés antimicrobiennes, utilisables en particulier pour la protection des matériaux organiques |
GB8313634D0 (en) * | 1982-06-18 | 1983-06-22 | Ici Plc | Halogenophenyl glyceride esters |
-
1983
- 1983-05-17 GB GB838313634A patent/GB8313634D0/en active Pending
- 1983-06-06 US US06/501,758 patent/US4587262A/en not_active Expired - Lifetime
- 1983-06-07 ZA ZA834135A patent/ZA834135B/xx unknown
- 1983-06-08 ZW ZW129/83A patent/ZW12983A1/xx unknown
- 1983-06-08 PH PH29022A patent/PH20587A/en unknown
- 1983-06-09 GR GR71595A patent/GR79196B/el unknown
- 1983-06-09 AT AT83303339T patent/ATE21686T1/de not_active IP Right Cessation
- 1983-06-09 EP EP83303339A patent/EP0099177B1/en not_active Expired
- 1983-06-09 DE DE8383303339T patent/DE3365634D1/de not_active Expired
- 1983-06-10 AU AU15698/83A patent/AU562207B2/en not_active Ceased
- 1983-06-10 IL IL68950A patent/IL68950A/xx unknown
- 1983-06-15 HU HU832121A patent/HU191531B/hu not_active IP Right Cessation
- 1983-06-15 PL PL24253583A patent/PL242535A1/xx unknown
- 1983-06-16 DK DK2782/83A patent/DK278283D0/da not_active Application Discontinuation
- 1983-06-17 CS CS843943A patent/CS241088B2/cs unknown
- 1983-06-17 JP JP58107998A patent/JPS5951240A/ja active Pending
- 1983-06-17 PT PT76889A patent/PT76889B/pt unknown
- 1983-06-17 NZ NZ204625A patent/NZ204625A/en unknown
- 1983-06-17 CA CA000430604A patent/CA1221983A/en not_active Expired
- 1983-06-17 CS CS834456A patent/CS241061B2/cs unknown
- 1983-06-17 IE IE1435/83A patent/IE55531B1/en unknown
- 1983-06-17 FI FI832227A patent/FI832227L/fi not_active Application Discontinuation
- 1983-06-17 NO NO832203A patent/NO832203L/no unknown
- 1983-06-17 DD DD83252126A patent/DD210029A5/de unknown
- 1983-06-17 ES ES523376A patent/ES523376A0/es active Granted
- 1983-06-18 KR KR1019830002729A patent/KR840005068A/ko not_active Application Discontinuation
-
1984
- 1984-03-16 ES ES530744A patent/ES530744A0/es active Granted
- 1984-03-16 ES ES530745A patent/ES8601295A1/es not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS394384A2 (en) | Zpusob pripravy novych halogenfenylesteru glyceridu | |
HUT35642A (en) | Process for preparing mevalonolactone analogues and derivatives thereof further pharmaceutical compositions containing such compounds | |
AU564910B2 (en) | Diazabicyclo-(3.3.1)nonanes | |
JO1704B1 (en) | New potent compounds | |
NZ211065A (en) | The use of quinolyloxy-containing compounds as phytotoxicity antidotes for fenoxaprop-ethyl | |
ES8105264A1 (es) | Un procedimiento para la preparacion de fenetanolaminas | |
GR79245B (el) | ||
AU1628988A (en) | Pharmaceutical compositions containing higher alcohols for the treatment of prostatic pathologies | |
ES8205810A1 (es) | Un procedimiento para preparar nuevos compuestos de cefem | |
ZA943342B (en) | The use of compositions for combating tumour diseases | |
FI851365L (fi) | Liposomer med inhalerbara allergener foer behandling av allergener, foerfarande foer deras framstaellning och dessa innehaollande laekemedel. | |
ES8607224A1 (es) | Un procedimiento para preparar esteres de acidos (alquilsulfonil)-metanosulfonicos | |
EP0285906A3 (en) | Active agent for combating tumours | |
IL98200A0 (en) | Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide | |
GB2110088B (en) | Compositions for the treatment of acne | |
IL99236A0 (en) | Pharmaceutical composition for the topical treatment of psoriasis | |
ZA824730B (en) | New antibiotic compounds, their production and their medicinal | |
GB2012166A (en) | Pharmaceutical composition for the treatment of asthma containing D-2-bromo-6-methyl- 8beta-(morpholinocarbonyloxymethyl) ergoline or its salts. | |
IL69194A0 (en) | Halogenated benzylphosphoric esters,their preparation and their use as fireproofing agents | |
PH22713A (en) | Iron compounds pharmaceutical compositions for the treatment of iron anaemia | |
ZA843615B (en) | 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles,processes for their preparation,as well as their use in the prophylaxis and therapy of thrombotic states | |
GB2012164A (en) | Pharmaceutical composition for the treatment of psychical disorders containing D-2-bromo-1,6- dimethyl-8beta-(perhydroazepinyl- carbonyloxymethyl) ergoline or its salts |